Yes, the Seretide inhaler, which contains a combination of a corticosteroid and a long-acting bronchodilator, can be associated with an increased risk of pneumonia, particularly in patients with chronic obstructive pulmonary disease (COPD). The corticosteroid component may suppress immune response in the lungs, making infections more likely. It's important for patients using Seretide to be aware of this risk and to report any signs of respiratory infections to their healthcare provider. Regular monitoring and proper inhaler technique can help mitigate potential risks.
Copyright © 2026 eLLeNow.com All Rights Reserved.